Home > Investor Centre
Investor Centre
Information about our corporate activities for current shareholders and potential investors.
Corum Group Limited is an Australian-owned, publicly listed company. Corum Group shares are listed on the Australian Securities Exchange (ASX) and are traded under the code COO. The company’s financial year runs from 1 July to 30 June, with half-year results announced in February and the full year results announced in August each year.
Announcements
PharmX Launches PharmXchange Platform
22 June 2022
Sigma signs long term PharmX agreement
3 May 2022
Notification of cessation of securities - COO
30 March 2022
H1 FY22 Interim Media Release and Results Presentation
10 February 2022
Half Yearly Report and Accounts
10 February 2022
PharmX Agreement - Supplementary Information
8 February 2022
Symbion & ProPharma sign long term PharmX agreement
7 February 2022
Notice of Results Announcement
4 February 2022
Notification of cessation of securities - COO
1 February 2022
Final Director’s Interest Notice - J Sallabank
1 February 2022
Resignation of Managing Director
1 February 2022
Corum Agrees Sale of eCommerce Business Unit
20 December 2021
Notification regarding unquoted securities - COO
10 December 2021
Trading Update
8 December 2021
Update on Legal Proceedings relating to PharmX
7 December 2021
Results of Annual General Meeting
24 November 2021
Chairman & CEO Address and AGM Presentation
24 November 2021
Key Retail Pharmacy Groups signed on to drive PharmX growth
23 November 2021
Corum Trading Update
29 October 2021
Notice of General Meeting/Proxy Form
22 October 2021
2021 Annual General Meeting Key Dates
10 September 2021
Corum extends relationship with Sigma into WholeLife
2 September 2021
Press Release and Investor Presentation
18 August 2021
Appendix 4E and Annual Report
18 August 2021
Appendix 4G and Corporate Governance Statement
18 August 2021
Notice of Results Announcement and Investor Presentation
10 August 2021
Investor Presentation
3 August 2021
Quarterly Activity Report and Appendix 4C
30 July 2021
Notification of cessation of securities - COO
14 July 2021
Show More
Update on Legal Proceedings
14 May 2021
Change of Share Registry
23 April 2021
Quarterly Activities Report and Appendix 4C
22 April 2021
H1 FY21 Interim Media Release and Results Presentation
24 February 2021
Half Yearly Report and Accounts
24 February 2021
HY 21 Reporting Date and Investor Presentation
17 February 2021
Quarterly Activities Report and Appendix 4C
29 January 2021
Change of Director’s Interest Notice Newbery
15 December 2020
Change of Director’s Interest Notice Shaw
10 December 2020
Initial Director’s Interest Notice Bastas
9 December 2020
Becoming a substantial holder Bastas
9 December 2020
Change of Director’s Interest Notice Shaw
8 December 2020
Appointment of Dennis Bastas as Director
3 December 2020
Change of Director’s Interest Notice
1 December 2020
Change of Director’s Interest Notice
30 November 2020
Proposed Issue of Securities - COO
19 November 2020
Results of Meeting
17 November 2020
CEO’s Address to Shareholders
17 November 2020
Chairman’s Address to Shareholders
17 November 2020
Release of ordinary shares from escrow
10 November 2020
Cleansing Notice
6 November 2020
Appendix 2A
6 November 2020
Proposed issue of Securities - COO
6 November 2020
Arrotex Pharmaceuticals becomes strategic shareholder
6 November 2020
Trading Halt
5 November 2020
Corum New Company Secretary Appointment
3 November 2020
Update on BAMM Agreement
30 October 2020
Appendix 4C - quarterly
30 October 2020
Initial Director’s Interest Notice
20 October 2020
Notice of Annual General Meeting and Explanatory Memorandum
16 October 2020
Jayne Shaw Joins Corum Board
15 October 2020
Change of Director’s Interest Notice
5 October 2020
Change of Director’s Interest Notice
2 October 2020
Becoming a substantial holder from AEF
1 October 2020
2020 Annual General Meeting Update
30 September 2020
Appendix 2A
29 September 2020
Cleansing Statement
29 September 2020
Completion of $5.6m Capital Raising
28 September 2020
Entitlement Offer - Extension of Closing date
15 September 2020
Indicative Timetable of Key Dates
10 September 2020
Despatch of Offer Booklet
9 September 2020
Update - Proposed issue of Securities
4 September 2020
Appendix 3Z Final Director’s Interest
4 September 2020
Corum Announces Completion of PharmX Acquisition
4 September 2020
Investor Presentation September 2020
1 September 2020
Entitlement Offer Letter to Ineligible Shareholders
1 September 2020
Proposed issue of Securities - COO
1 September 2020
Offer Booklet
1 September 2020
Cleansing Statement
1 September 2020
Acquisition of Remaining 57% interest in PharmX
1 September 2020
Corum New Company Secretary Appointment
1 September 2020
Corum Executive Management Changes
1 September 2020
Trading Halt
31 August 2020
Appendix 4G & Corporate Governance Statement
24 August 2020
Appendix 4E and Annual Report
24 August 2020
Corum Group Annual Report 2020
24 August 2020
Appendix 3B - Performance Rights Issues
21 August 2020
Change of Auditor - Audit Practice Restructure
21 August 2020
Appendix 4C - quarterly
7 August 2020
Update on BAMM Agreement
30 June 2020
Initial Director’s Interest Notice
16 April 2020
Director Appointment
16 April 2020
Appendix 4C - quarterly
1 April 2020
Corum to increase ownership in PharmX
24 March 2020
Change of Director’s Interest Notice
4 March 2020
Change of Director’s Interest Notice
4 March 2020
Initial Director’s Interest Notice
2 March 2020
Director Appointment
25 February 2020
Director Resignation and Final Directors Interest Notice
24 February 2020
Initial Director’s Interest Notice
19 February 2020
Final Director’s Interest Notice
19 February 2020
Chairman Retirement
19 February 2020
Half Yearly Report and Accounts
18 February 2020
Management Incentive Plan
18 February 2020
Appendix 4C - quarterly
31 January 2020
Update on Court Proceedings
23 December 2019
Ceasing to be a substantial holder
6 December 2019
Board Succession
2 December 2019
Ceasing to be a substantial holder
26 November 2019
Investor Group Substantial shareholder notice 603
21 November 2019
Director Appointment
21 November 2019
Completion of Share Placement
21 November 2019
Cleansing Statement Section708A(5)(e)
21 November 2019
Change in substantial holding
21 November 2019
Initial director’s Interest Notice
21 November 2019
Appendix 3B - Capital Raise
21 November 2019
AGM Results Poll
20 November 2019
Ceasing to be Substantial shareholder notice change 605
20 November 2019
Chairman’s Address
20 November 2019
Waiver From Listing Rule 7.3.2
12 November 2019
Addendum to Notice of Annual General Meeting
11 November 2019
Response to ASX price query
8 November 2019
Appendix 4C Quarterly
31 October 2019
Notice of Annual General Meeting & Proxy Form
18 October 2019
Directorship
18 October 2019
Corum secures strategic partnership
11 October 2019
Substantial holder notice
8 October 2019
Corum structured for growth
27 September 2019
Trading Halt
25 September 2019
SaaS technolgy collaboration agreement
24 September 2019
Appendix 4G and Corporate Governance Statement
29 August 2019
Appendix 4E and Annual Report
29 August 2019
Results of EGM
25 February 2019
Half Yearly Results Announcement
22 February 2019
Half Yearly Results and Accounts
22 February 2019
Notice of EGM / Proxy Form
18 February 2019
Corum Clear Dispense Update
26 January 2019
EGM ASX Waiver
25 January 2019
AGM Chair and CEO Address
28 November 2018
Results of Annual General Meeting
28 November 2018
Notice of Annual General Meeting and Explanatory Memorandum
26 October 2018
Appendix 4E Preliminary final report
29 August 2018
Corum Clear Update
20 July 2018
Half Yearly Report and Accounts
28 February 2018
Corum signs up to My Health Record
29 November 2017
Results of Meeting
29 November 2017
Chairman and CEO Address to Shareholders
29 November 2017
Notice of Annual General Meeting/Proxy Form
27 October 2017
Annual Report to shareholders
27 October 2017
Appendix 4G - Corporate Governance
1 September 2017
Appendix 4E and Annual Accounts
31 August 2017
Corum announces expected non-cash impairment
25 August 2017
Change of Director’s Interest Notice
20 March 2017
Half Yearly Report and Accounts
24 February 2017
Half-Year Report Investor Update
24 February 2017
Appointment of Chief Executive Officer
24 January 2017
Appendix 3B - Exercise of Performance Rights
13 December 2016
Chairman’s Address to Shareholders
2 November 2016
Results of Meeting
2 November 2016
Annual Report to shareholders
30 September 2016
Notice of General Meeting/Proxy Form
30 September 2016
Change of Director’s Interest Notice
20 September 2016
Change of Director’s Interest Notice
15 September 2016
Change of Director’s Interest Notice
9 September 2016
Appendix 4E and Annual Report
31 August 2016
Appendix 4G - Corporate Governance
31 August 2016
Trading Update
13 July 2016
Chief Executive Officer Appointment
11 March 2016
Change of Director’s Interest Notice
9 March 2016
Change of Director’s Interest Notice
3 March 2016
Half Yearly Report and Accounts
29 February 2016
Company Update
29 February 2016
Reinstatement to Official Quotation
29 February 2016
Suspension from Official Quotation
25 February 2016
Trading Halt
23 February 2016
Appointment of Executive Director
11 January 2016
Response to ASX Price Query
29 December 2015
Change of Director’s Interest Notice
10 December 2015
Change of Director’s Interest Notice
26 November 2015
Change of Director’s Interest Notice
26 November 2015
Chairman’s Address to Shareholders
19 November 2015
Results of Meeting
19 November 2015
Director Appointment/Resignation
2 November 2015
Final Director’s Interest Notice
2 November 2015
Final Director’s Interest Notice
2 November 2015
Managing Director / CEO Resignation
28 October 2015
Appendix 3B - Exercise of Performance Rights
26 October 2015
Annual Report to shareholders
19 October 2015
Notice of Annual General Meeting/Proxy Form
19 October 2015
Appendix 4G - Key to Corporate Governance Disclosures
19 October 2015
Final Director’s Interest Notice
28 August 2015
Preliminary Final Report
27 August 2015
FY15 Results Announcement
27 August 2015
FY15 Company Presentation
27 August 2015
Director Appointment
21 August 2015
Initial Director’s Interest Notice
21 August 2015
Director Resignation
19 August 2015
Details of Company Address
18 August 2015
Appendix 3B - Employee Share Scheme
3 July 2015
Performance Rights Lapse
5 June 2015
Chairman and Director Appointments
20 May 2015
Initial Director’s Interest Notice
20 May 2015
Initial Director’s Interest Notice
1 May 2015
Director Appointment / Company Secretary Resignation
27 April 2015
Appendix 4C - quarterly and commentary
27 April 2015
Final Director’s Interest Notice
10 April 2015
Chairman Retirement
2 April 2015
Director Appointment
20 March 2015
Initial Director’s Interest Notice
20 March 2015
Acting MD / CEO - Terms of Appointment
19 March 2015
Response to ASX Query
24 February 2015
Company Secretary Appointment
20 February 2015
Half Yearly Report and Accounts
18 February 2015
Final Director’s Interest Notice
13 February 2015
Change in Managing Director / Chief Executive Officer
30 January 2015
Appendix 4C - quarterly
28 January 2015
Dividend Declaration
28 January 2015
Expiry of Employee Share Options
16 December 2014
Appendix 3B - exercise of options
15 December 2014
Appendix 3B - exercise of options
27 November 2014
Chairman’s Address to Shareholders
19 November 2014
Results of Meeting
19 November 2014
Notice of General Meeting/Proxy Form
17 October 2014
Appendix 4C - quarterly
15 October 2014
Show Less